key: cord-0300925-xzbbmy34
authors: Zuccarello, Pietro; Emma, Rosalia; Caruso, Massimo; Pulvirenti, Roberta; Rust, Sonja; Poulas, Konstantinos; Zadjali, Fahad; Boffo, Silvia; Volarevic, Vladislav; Lesmana, Ronny; Abdulkhakov, Sayar R; Mesiakaris, Konstantinos; Tobi, Mohammed Al; Giordano, Antonio; Arsenijevic, Aleksandar; Barliana, Melisa I; Kitaeva, Kristina V; Polosa, Riccardo; Volti, Giovanni Li; Ferrante, Margherita
title: Nicotine measurement on Cambridge Filter PADs: an interlaboratory comparison to evaluate exposure by different electronic devices and traditional cigarette
date: 2022-04-10
journal: bioRxiv
DOI: 10.1101/2022.04.07.487344
sha: 8f4ffbbcd2549a98772ab282d1feb24df84926dc
doc_id: 300925
cord_uid: xzbbmy34

Inter-laboratory comparison is widely used to ensure quality control among laboratories. In in vitro toxicology studies for tobacco harm reduction (THR), exposure system performance and laboratory proficiency along with product smoke and aerosol stream are tested for variability to assess accuracy. Here we aim to test a novel inter-laboratory setup created in a new collaborative research group using identical and small footprint systems- in order to minimize variability factors and increase reproducibility. Seven independent laboratories from different geographical areas tested the aerosol and smoke stream and exposure system performance (LM1 and LM4E) using Cambridge Filter Pad (CFP) trapping techniques. We tested 1R6F reference cigarettes, two electronic cigarettes (Vype e-Pen and Vype e-Stick Maxx), and two tobacco heating products (IQOS and Glo™) under the appropriate ISO and/or HCI regimes. Nicotine quantification was performed by GC-FID at the laboratory of the leading center. The performance of participant laboratories was assessed by z-score values obtained from results either in relation to the mean and standard deviation of total participants or in relation to the reference leading center. Z-Scores were satisfactory when |z| ≤ 2, questionable when 2 < |z| < 3 and, unsatisfactory when |z| ≥ 3. In the first evaluation, for all the tested devices, Z- scores values generated by dosimetry data ranged from -2 to +2. However, high intra-laboratory variability (RSD> 10%) was observed for almost all laboratories. In the second, data showed borderline and unsatisfactory exposure performances versus LAB-A. Particularly, Z-scores ≥ 3 were observed once for LAB-B (e-Stick exposure) and LAB-G (e-Pen exposure), twice for LAB-C (1R6F-ISO and e-Stick exposures) and LAB-E (e-Pen and e-Stick exposures), and three times for LAB-F (1R6F-HCI, e-Pen, and Glo exposures). This study demonstrates that nicotine dosimetry is a fundamental method for quality assurance of smoke/vapor run exposure in the early stage of an interlaboratory study, allowing the identification and possibly the resolution of gaps. Extended practice sessions on exposure runs and several rounds of nicotine dosimetry testing should be planned to keep in check overall equipment and operator performance.

The Replica Project is a multicenter study that aims to verify the results of published studies from the tobacco industry and carries the underlined mission to promote research on tobacco Harm Reduction in countries where R&D capacity is needed, including low and middle-income countries [1] .

Collaborative research in this field and in in vitro research should not be limited to developed countries which directly impact regulatory policy worldwide. Other nationalities should be involved in this type of research and contribute to this discourse from the initial stages of methodology standardization. For this reason, we initiated a collaboration with countries where harm reduction from smoke is relevant and the need for regulatory impact at the local level is necessary.

The use of a multicenter design has been chosen as a method to improve reproducibility and to produce consistent results. In this study, selected international laboratories independently conducted research experiments using shared standard operative procedures (SOPs) in order to obtain consistent results in terms of biological effect. For this purpose, accuracy of smoke and vapor exposure runs is pivotal in supporting the biological testing of next generation nicotine and tobacco products with diverse chemical profiles. Then, interlaboratory comparisons is an important part of quality assurance programs for any multicenter study allowing: I) an assessment of interlaboratory variation; II) identification of any problems , their source, and magnitude; III) to test procedures, equipment performance and the laboratory staff proficiency; IV) to assess agreement and reliability of results [2] .

The CORESTA in vitro Toxicology Task Force recommends the use of chemical analysis of nicotine content, as well as possibly other constituents, in order to confirm the acceptable performance of the smoking machine and for accuracy within smoking samples [3] . Nicotine is a good analyte to be evaluated as it is common among the inhalable products we want to assess, including cigarettes, electronic cigarettes (e-cig), and tobacco heating products (THPs). Moreover, nicotine quantification on Cambridge filter pads (CFPs) is a simple method to perform, and it is used in several studies as a dosimetry marker to assess in vitro exposure systems [4] [5] [6] .

CFPs are glass fiber filters able to retain at least 99.9 % of all particles contained in tobacco smoke or e-cig aerosol (Total Particulate Matter or TPM) [7, 8] , and they are efficient in trapping nicotine at source for both cigarette smoke (at least 99.9%) and e-cig aerosol (> 98%) [9] . In a previous study, we investigated different storing conditions able to guarantee the preservation and stability of the nicotine trapped on CFPs. Results from that study showed that different exposure regimes and products can affect the preservation of nicotine titer on CFPs while sample storage at -80 °C prevented the loss of nicotine for at least 30 days [10] . Based on these results, we centralized shipment of nicotine dosimetry samples to our chemistry lab which performed both extraction and chemical analysis so as to minimize bias and variability of results due to nicotine extraction procedures and distinct analyzers.

In this study, we performed an interlaboratory comparison of seven independent laboratories located in different geographical areas by nicotine quantification at source in order to verify repeatability and reproducibility, to describe the pattern of variation, and to identify laboratories producing discrepant results. Particularly, we assessed the nicotine yield in CFP using the same test products intended for our in vitro research [1] , including reference cigarette 1R6F, two electronic cigarettes (Vype e-Pen and Vype e-Stick Maxx), and two THPs (IQOS 3 Duo and Gloä Pro).

The international partners involved in the REPLICA project were recruited by using online questionnaires as described by Caruso and colleagues (1) . Seven laboratories participated in this study: Italy (LAB-A; leading center), Greece (LAB-B), Oman (LAB-C), USA (LAB-D), Serbia (LAB-E), Indonesia (LAB-F), and Russia (LAB-G). The leading laboratory with expertise on smoke and vapor exposure was the LAB-A. In the first phase of harmonization, resources, checklist templates and evaluation procedures were supplied to the team for workshop sessions and hands-on training held in the leading center, then followed by on-site calibration and system maintenance training provided by a certified service engineer and ultimately on-site laboratory capacity compliance and personnel expertise assessments by the leading scientists. Additional on-site training and planned cross border researcher exchange could not be carried out due to unforeseen events (pandemic insurgence). Moreover, detailed SOPs on smoke/vapor CFP exposure method and lab environmental conditions (ISO3308) were reviewed and harmonized across all centers according to the Center for Open Science transparency and openness promotion guidelines (https://www.cos.io/initiatives/top-guidelines). Equipment set up was also harmonized to minimize variability. Precheck lists, schedule and shipment guidelines were made available on our cloud platform as well as written guidelines and datasheet templates used for data collection and technical data recording related to critical protocol steps and environmental status reporting. Partner sample shipments were initially planned to occur during the same time frame. The feasibility was stunted due to university closings and outbreaks and lead time was extended on a case-to-case basis. Individual folders on our dedicated cloud platform were assigned to each laboratory in order to collect data, maintain privacy and prevent bias. To further minimize the variability, all the participating laboratories used the same exposure equipment, the same consumables and key products with the same lot number, except for 1R6F reference cigarettes which were separately bought from each laboratory to avoid custom issues. Authorization to change to alternative products was required.

The following products were used for CFP exposure: 1R6F reference cigarettes (University of Reference cigarettes 1R6F were smoked to the length of the filter overwrap +8 mm using both ISO regime (35 mL puff volume, drawn over 2 s, once every minute with ventilation holes unblocked) and HCI regime (55 mL puff volume, drawn over 2 s, once every 30 s with ventilation holes blocked).

The smoke generated by each cigarette was captured in line on a 44 mm diameter CFP ( Figure 1 ). Vype ePen3 was vaped following a modified HCI regime (55 mL puff volume, drawn over 2 s, once every 30 s with square shape profile) plus 1 s of pre-activation, for 15 puffs per CFP. Vype eStick Maxx was vaped under CRM81 regime (55 mL puff volume, drawn over 3 s, once every 30 s with square shape profile) for 15 puffs per CFP. Both Heetsticks and Neosticks were puffed following the HCI regimen but with filter vents unblocked for respectively 12 and 8 puffs. The aerosol generated by each e-cig and THP was captured in line on a 44 mm diameter CFP ( Figure 2 ).

Six replicates of each exposure were performed by each laboratory. Each exposed CFP was weighed before and after smoke/vapor exposure in order to quantify the total particulate matter (TPM) and the aerosol mass (AM). After exposure, each CFP sample was transferred into a clean 15 ml tube labeled as described in SOP.

According to our guidelines all the CFP samples were stored at -80 °C, and then shipped with a datalogger in dry ice to LAB-A for nicotine quantification within 30 days after exposure

Nicotine stock solution at concentration of 100 μg/μL was prepared by weighing 1 g of nicotine at purity of 99% (Sigma Aldrich) into a 10 mL volumetric flask and diluted to volume with acetone. 

Mean and standard deviation (SD) were calculated for each product tested in the different laboratories. Precision was assessed by computing the Relative Standard Deviation (RSD%) as the percentage ratio between SD and the mean value. The performance of participant laboratories was evaluated for each tested product by z-scores calculation [11] .

The z-score is calculated with Equation:

z-score = xi − xpt/SD Where:

-for the first evaluation "Z-Scores vs All", xi is the value obtained by each participant, xpt and SD are respectively the mean and the standard deviation generated from the total participants; -for the second evaluation "Z-Scores vs Lab-A", xi is the value obtained by each participant, xpt and SD are respectively the mean and the standard deviation generated from the leading center, i.e. Lab-A;

The evaluation of the results was made according to EN ISO/IEC 17043:2010 [12] , as follows:

• satisfactory, when |z| ≤ 2;

• questionable, when 2 < |z| < 3;

• unsatisfactory, when |z| ≥ 3.

All analyses were performed by using RStudio Software (Version 1.2.5001)

Z-scores were calculated on the basis of the mean and standard deviation of the results generated by the total participating laboratories. For all tested devices (1R6F under ISO and HCI regimes, e-Pen, e-Stick, IQOS, and Glo), Z-scores generated by inter laboratory sample analysis range from -2 to +2. In Table 1 and Figure 3 are reported the descriptive statistics and Z-Scores of results generated from all participating laboratories for each lab and each device. Although the Z-Scores are within the satisfactory range, the RDS% values (range from 17% to 29%) showed high intra-laboratory variability among all participants. The LAB-A and LAB-G exhibited a higher precision than the others with all RSD% ≤ 10% except for the RSD% of Glo (13%). Instead, the RSD% of all other laboratories were mostly ≥ 10%, and only in few conditions the RDS% were below the 10%. Further, Z-scores have been calculated based on the mean and standard deviation of reference laboratory (LAB-A) (see Table 2 and Figure 4) . These results showed that a substantial number of exposure runs significantly deviated from LAB-A. As per questionable values (2 < |z| <3), these was 

Combined Nicotine dosimetry and CFP trapping techniques were used here to assess smoking and vaping exposure system performance for product testing and comparison. This was performed under an inter-laboratory setting across several geographical areas. From the data generated across all labs we observed agreement when the z-scores were calculated versus the overall mean. Instead, variability was observed for some laboratories when z-scores were calculated versus the mean of LAB-A (leading center).

The first step to evaluate different exposure systems in an in vitro interlaboratory study is the assessment of aerosol generation accuracy. Without this step, any subsequent in vitro data generated with these systems cannot produce reliable data [13] . Dosimetry of nicotine can assess many aspects of smoke and vapor exposures. It can allow several test products for direct comparison, be used as a quality assurance tool during exposure, and demonstrate physiologically relevant exposure [5, 6, 13] .

CFP trapping method is used to trap aerosol and smoke compounds at source avoiding loss so as to reduce variability due to equipment artifacts. To further minimize the variability and improve reproducibility of results across the board, all partners received the same exposure systems and accessories for smoking and vaping experimental set up, and the same test product lot (except to 1R6F reference cigarettes). Moreover, based on previous published data on nicotine stability in CFP, extraction and analysis have been performed by the leading center in order to avoid bias and variability. Samples were shipped and stored according to our previous study showing that freezing at -80 °C preserves nicotine stability on CFPs for at least one month [10] . Also, internal standards were included.

Two types of analysis were performed on the collected data. The first, by comparing each lab data to the average value of all laboratory results. From this analysis, all the Z-scores of each laboratory fall into the satisfactory range (from -2 to +2) suggesting a good reproducibility of exposures. The second analysis was performed by comparing data from each lab with the mean of the leading laboratory results. We used the data of LAB-A as a reference laboratory because LAB-A was more experienced in performing smoke and vapor exposures. Moreover, LAB-A showed minor variability (between 4 and 13%) in their exposure data. Indeed, comparing interlaboratory data overall, the results indicated that the precision achieved under the same conditions by the leading center further validates its role as laboratory reference. The comparison between the REPLICA partners and the leading center has shown that most laboratories were outside the parameters on one or more occasions indicating poor reproducibility. Only LAB-D presented Z score values between -3 and +3 for all test exposures and conditions. LAB-B and LAB-G underperformed only once. LAB-C and LAB-E performances were unsatisfactory for two conditions. However, LAB-F underperformed on three accounts, and the other three exposure performances showed Z-score > 2. From a product stand point, the two electronic cigarettes, e-Pen and e-Stick, gave the weakest reproducibility values across all labs, and IQOS exposures exhibited high intra-laboratory variability for four out of seven laboratories. Considering product mouthpieces, shape and activation type, port-device interface handling along with general expertise in using smoking/vaping machines are two key points to highlight.

The present study raises some important issues regarding the difficulty of harmonizing interlaboratory performance in newly formed collaborations under limited in-person training, despite the use of the same equipment and key products, suggesting that data variability may be attributable to the exposure stage. Apart from variations of supposedly identical test products, the following factors may contribute to the variability of a test procedure: the operator, calibration of equipment, environmental conditions (temperature, humidity, air pollution, etc.), time elapsed between measurements. The comparison with the leading center undoubtedly has shown the difficulty to minimize variability and the need to further address each stage of the harmonization process. The current literature on inhalation products also addresses the same concerns [13, 14] .

COVID-19 pandemic was another factor that indirectly affected the results. During the pandemic insurgence, the technical personnel of the smoking machines producer had to shorten their stay or had to support lab technicians with virtual guidance to set up the equipment. Hence, we cannot exclude possible calibration issues in those laboratories.

Partner sample shipments were initially planned to occur at the same time. The feasibility was stunted due to university closings, outbreaks, airport shutdowns and crippled logistics, therefore lead time had to be extended on a case by case basis over a 16 month period. Analyses were not performed as scheduled and some delays on the 30 day stability window may have impacted the results.

The initial data collected had early indicators of variability leading us to reassess our harmonization strategy. In this second phase we were able to pinpoint some of these issues and come up with several solutions, including remote support and assistance during exposure sessions, videos of critical steps and SOPs enriched with photos and schematic representations. Additional on-site training and planned cross border researcher exchange could not be carried out. Most of the performed on-site compliance checks and training were time limited and therefore we switched to a virtual format. The latter was implemented post initial data assessment, clearly indicating that additional training was needed. As part of a contingency plan we strengthen our virtual role and our digital platform by providing interactive lab support sessions and creating multimedia resources with lab videoclips to satisfy the gaps on visual technical resources in this niche environment -smoke and aerosol exposure systems.

Undoubtedly, although technology is an excellent tool for supporting scientific needs, it cannot be a substitute for direct interaction, especially in a newly formed international collaboration. However, the initial data received gave us time to refine our measures, improve communication and reassess with our partners the areas that needed to be improved: instrument maintenance and cleaning, proper test product conditioning and handling, and clarification on procedural issues. Since in person training was not feasible, we resorted to optimizing guided practice through interactive lab video sessions and videoclips of key exposure processes. Because of time constraints we were not able to repeat the dosimetry. However, results of bioassays later performed are evidence of agreement within laboratories [1] . Hence, our interventions during the second phase have shown to be effective. We plan to repeat nicotine dosimetry testing prior to further research.

There are a few considerations and recommendations to this study which the authors acknowledge.

Dosimetry methods (e.g nicotine quantification) should be used repeatedly when an interlaboratory study on smoke and vapor exposure is planned in order to provide quality assurance of the exposure methods. Training exercises in exposure runs should be also planned as a continuum in an interlaboratory study since time and space can be a limiting factor for laboratories with limited smoke and aerosol exposure system experience. 

Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project

Interlaboratory Comparisons: Lessons Learned

Rationale and Strategy for In Vitro Toxicity Testing of Combustible Tobacco Products

Characterisation of the borgwaldt LM4E system for in vitro exposures to undiluted aerosols from next generation tobacco and nicotine products (NGPs)

Nicotine quantification in vitro: a consistent dosimetry marker for ecigarette aerosol and cigarette smoke generation. Applied In Vitro Toxicology

Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems

ISO International Organization for Standardization, ISO/DIS 24197 Vapour products -Determination of e-liquid vaporised mass and aerosol collected mass

Role of the Filters in the Formation and Stabilization of Semiquinone Radicals Collected from Cigarette Smoke

Particle size distribution of e-cigarette aerosols and the relationship to Cambridge filter pad collection efficiency

Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions

Statistical methods for use in proficiency testing by interlaboratory comparison

ISO International Organization for Standardization, ISO/IEC 17043:2010 Conformity assessment -General requirements for proficiency testing

An interlaboratory in vitro aerosol exposure system reference study

Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations